Electrophysiology to predict mechanical ventilation in Guillain-Barré syndrome

European Journal of Neurology

Volumn 10, Issue 1, 2003, Pages 39-44

  Durand, M C ^a   Lofaso, F ^a   Lefaucheur, J P ^b   Chevret, S ^c   Gajdos, Ph ^d   Raphaël, Jean Claude ^d,e   Sharshar, T ^d  

^a Lab d'Explorations Fonctionnelles   (France)

^b Lab d'Explorations Fonctionnelles   (France)

^c Dept de Biostatistique et Info M ^*  (France)

^d Serv de Reanimation Med   (France)

^e RAYMOND POINCARÉ HOSPITAL   (France)

Author keywords

Demyelinating neuropathy; Electrophysiological study; Guillain Barr syndrome respiratory failure

Indexed keywords

IMMUNOGLOBULIN;

ADULT; ARTICLE; ARTIFICIAL VENTILATION; CONTROLLED STUDY; DEMYELINATING DISEASE; ELECTROPHYSIOLOGY; FEMALE; GUILLAIN BARRE SYNDROME; HOSPITAL ADMISSION; HUMAN; INTENSIVE CARE; MAJOR CLINICAL STUDY; MALE; NERVE FIBER DEGENERATION; PLASMAPHERESIS; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; CHI-SQUARE DISTRIBUTION; ELECTROPHYSIOLOGY; FEMALE; FORECASTING; GUILLAIN-BARRE SYNDROME; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RESPIRATION, ARTIFICIAL; STATISTICS, NONPARAMETRIC;

EID: 0037238054     PISSN: 13515101     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1468-1331.2003.00505.x     Document Type: Article

References (28)

1. Alam T, Chaudry V, Cornblath D (1998). Electrophysiological studies in Guillain-Barré syndrome distinguishing the subtypes. Muscle Nerve 21:1275-1279.
2. Alberts J, Donofrio P, McConagle T (1985). Sequential electrodiagnostic abnormalities in acute inflammatory polyradiculoneuropathy. Muscle Nerve 59:504-509.
3. Asbury A, Cornblath D (1990). Assessment of current criteria for Guillain-Barré syndrome. Ann Neurol 27:21-24.
4. Bolton C (1993). Clinical neurophysiology of the respiratory system. Muscle Nerve 16:806-818.
5. Clouston P, Kiers L, Zuniga G, Cros D (1994). Quantitative analysis of the compound muscle action potential in early acute inflammatory demyelinating polyneuropathy. Electroencephal Clin Neurophysiol 93:255-264.
6. Cornblath D, Mellits E, Griffin J et al. (1988). Motor conduction studies in Guillain-Barré syndrome. Description and prognostic values. Ann Neurol 23:354-359.
7. Créange A, Sharshar T, Planchenault TCC, Poron F, Raphaël J, RKG (1999). Matrix metalloproteinase-9 is increased and correlates with severity in Guillain-Barré. Neurology 53:1683-1691.
8. French Collaborative Group on Plasma Exchange in Guillain-Barré Syndrome (1997) Appropriate number of plasma exchanges in Guillain-Barré Syndrome. Ann Neurol 41:298-306.
9. Gourie-Devie M, Ganapathy G (1985). Phrenic nerve conduction time in Guillain-Barré syndrome. J Neurol Neurosurg Psychiatry 48:285-292.
10. Griffin J, Li C, Ho T et al. (1995). Guillain-Barré syndrome in northern China: the spectrum of neuropathological changes in clinically defined cases. Brain 118:577-595.
11. Griffin J, Li C, Macko C et al. (1996). Early nodal changes in acute motor axonal neuropathy pattern of the Guillain-Barré syndrome. J Neurocytol 25:33-51.
12. Hadden R, Cornblath D, Hughes R et al. (1998). Electrophysiological classification of Guillain-Barré syndrome: clinical associations and outcome. Ann Neurol 44:780-788.
13. Hadden R, Karch H, Hartung H et al. (2001). Preceding infections, immune factors and outcome in Guillain-Barré syndrome. Neurology 56:758-765.
14. Hafer Macko C, Hsieh S, Ho T et al. (1996). Acute motor axonal neuropathy: an antibody-mediated attack on axolemna. Ann Neurol 40:635-644.
15. Ho T, Mishu B, Li C et al. (1995). Guillain-Barré syndrome in northern China. Relationship to Campylobacter jejuni infection and anti-glycolipid antibodies. Brain 118:597-605.
16. Ho T, Hsieh S, Nachamkin I et al. (1997a). Motor nerve terminal degeneration provides a potential mechanism for rapid recovery in acute motor axonal neuropathy after Campylobacter infection. Neurology 48:717-724.
17. Ho T, Li C, Cornblath D et al. (1997b). Patterns of recovery in the Guillain-Barré syndromes. Neurology 48:695-700.
18. Kieseier B, Clements J, Pischel H et al. (1998). Matrix metalloproteinases MMP-9 and MMP-7 are expressed in experimental autoimmune neuritis and the Guillain-Barré syndrome. Ann Neurol 43:427-434.
19. Lawn N, Fletcher D, Henderson R, Wolter T, Wijdicks E (2001). Anticipating mechanical ventilationin Guillain-Barré syndrome. Arch Neurol 58:893-898.
20. Meulstee J, Van der Meche F (1995). Electrodiagnostic criteria for polyneuropathy and demyelinisation: application in 135 with Guillain-Barré syndrome. J Neurol Neurosurg Psychiatry 59:482-486.
21. Oh SJ (1993). Normal values for common nerve conduction tests. In: David C. Retford, ed. Clinical Electromyography: Nerve Conduction Studies, Vol. 7. Williams & Wilkins, Baltimore, 84 p.
22. Plasma Exchange Sandoglobulin Guillain-Barré Syndrome Trial Group (1998) Randomised trial of plasma exchange intravenous immunoglobulin and combined treatments in Guillain-Barré syndrome. Lancet 349:225-230.
23. Rees J, Gregson N, Hugues R (1995). Anti-ganglioside GM1 antibodies in Guillain-Barré syndrome and their relationship to campylobacter jejuni infection. Ann Neurol 38:809-816.
24. Ropper A, Wijdicks E, Shahani B (1990). Electrodiagnosis abnormalities in 113 consecutive patients with Guillain-Barré syndrome. Arch Neurol 47:881-887.
25. Sharief M, Ingram D, Swash M (1997). Circulating tumor necrosis factor-alpha correlates with electrodiagnostic abnormalities in Guillain-Barré syndrome. Ann Neurol 42:68-73.
26. Takigawa T, Yasuda H, Kikkawa R (1995). Antibodies against GM1 ganglioside affect K+ and Na+ currents in isolated rat myelinated nerve fibers. Ann Neurol 37:436-442.
27. Visser L, van der Meché F, Meulstee J et al. (1996). Cytomegalovirus infection and Guillain-Barré syndrome: the clinical, electrophysiologic, and prognostic features. Neurology 47:668-673.
28. Zifco U, Chen R, Remtulla H, Hahn A, Koopman W, Bolton C (1996). Respiratory electrophysiological studies in Guillain-Barré syndrome. J Neurol Neurosurg Psychiatry 60:191-194.